These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38658965)

  • 41. Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy.
    Yang L; Wang Z; Gong H; Gai S; Shen R
    J Colloid Interface Sci; 2023 Mar; 634():495-508. PubMed ID: 36542978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
    Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
    Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor Microenvironment-Responsive Biodegradable Nanomedicine for Self-Enhanced Synergistic Chemo-, Photothermal, and Chemodynamic Therapy.
    Tang HX; He ZH; Liu CG; Zheng XK; Zhang ZJ
    ACS Appl Mater Interfaces; 2024 Oct; 16(39):52023-52035. PubMed ID: 39303011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptide-IR820 Conjugate: A Promising Strategy for Efficient Vascular Disruption and Hypoxia Induction in Melanoma.
    Zhang H; Jiang M; Xing W; Zhao R; Li G; Zheng Z
    ACS Appl Mater Interfaces; 2024 Aug; 16(31):40641-40652. PubMed ID: 39051862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy.
    Zhang MK; Li CX; Wang SB; Liu T; Song XL; Yang XQ; Feng J; Zhang XZ
    Small; 2018 Dec; 14(50):e1803602. PubMed ID: 30370690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced photo-hypoxia-activated combination therapy traced by AIE photosensitizer and targeted by hyaluronic acid: Disulphide bond interference of detoxification barrier.
    Ouyang F; Zhang X; Zhang L; Liu Y; Shuai Q
    J Photochem Photobiol B; 2022 Sep; 234():112535. PubMed ID: 35930948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune remodeling triggered by photothermal therapy with semiconducting polymer nanoparticles in combination with chemotherapy to inhibit metastatic cancers.
    Yang Y; Xu M; Wang Z; Yang Y; Liu J; Hu Q; Li L; Huang W
    J Mater Chem B; 2021 Mar; 9(11):2613-2622. PubMed ID: 33683252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer.
    Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y
    J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
    Zhang L; Fan Y; Yang Z; Yang M; Wong CY
    J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multifunctional Carbon Monoxide Prodrug-Loaded Nanoplatforms for Effective Photoacoustic Imaging-Guided Photothermal/Gas Synergistic Therapy.
    Lin Y; Zhong W; Wang M; Chen Z; Lu C; Yang H
    ACS Appl Bio Mater; 2021 May; 4(5):4557-4564. PubMed ID: 35006792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic-Covalent Hydrogel with NIR-Triggered Drug Delivery for Localized Chemo-Photothermal Combination Therapy.
    Sun P; Huang T; Wang X; Wang G; Liu Z; Chen G; Fan Q
    Biomacromolecules; 2020 Feb; 21(2):556-565. PubMed ID: 31804804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy.
    Jiang Y; He S; Xiang N; Duan L; Lin Y; Huang W; Wu Z; Qi X
    Nanoscale; 2024 Aug; 16(34):15967-15983. PubMed ID: 39101331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
    Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
    ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A versatile nanoplatform for synergistic chemo-photothermal therapy and multimodal imaging against breast cancer.
    Li T; Geng Y; Zhang H; Wang J; Feng Y; Chen Z; Xie X; Qin X; Li S; Wu C; Liu Y; Yang H
    Expert Opin Drug Deliv; 2020 May; 17(5):725-733. PubMed ID: 32098527
    [No Abstract]   [Full Text] [Related]  

  • 58. Mitochondria-Targeting MoS
    Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyaluronic acid-coated Bi:Cu
    Cheng Y; Bo H; Qin R; Chen F; Xue F; An L; Huang G; Tian Q
    J Nanobiotechnology; 2022 Jul; 20(1):346. PubMed ID: 35883134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-temperature PTT/CDT coordination nanoplatform realizing exacerbated hypoxia for enhancing hypoxia-activated chemotherapy to overcome tumor drug resistance.
    Chang P; Guo Y; Chen D; Li K; Wang W; Yang Z; Ma J; Zeng Y; Zhan W; Zhan Y
    J Nanobiotechnology; 2024 Jun; 22(1):374. PubMed ID: 38926723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.